壳聚糖纳米粒作为药物递送系统在癌症治疗中的应用

被引：22

作者：

孙仁凇 ^{[1
]}

张建斌 ^{[1
]}

房佳霓 ^{[1
]}

吕侠 ^{[2
]}

唐泽耀 ^{[1
]}

田燕 ^{[1
]}

机构：

[1] 大连医科大学药学院

[2] 大连医科大学中西医结合学院

来源：

中国临床药理学与治疗学 | 2021年 / 26卷 / 01期

关键词：

壳聚糖; 药物递送系统; 癌症治疗;

D O I：

暂无

中图分类号：

R943 [制剂学];

学科分类号：

100702 [药剂学];

摘要：

癌症是威胁人类生存的恶性疾病之一。近年来,利用纳米技术将药物靶向递送到肿瘤部位,可以增加疗效并降低毒性,为癌症治疗带来了新希望。壳聚糖是自然界唯一存在的碱性多糖,具有良好的生物相容性和生物可降解性。此外,其反应位点多,可制成不同性质的衍生物,广泛用于药物递送系统和组织工程支架,在生物医药领域具有重要的应用价值。本综述对近年来壳聚糖纳米粒在抗癌药物递送方面的研究进展进行介绍,重点介绍了壳聚糖纳米粒的制备、被动靶向、主动靶向和刺激-响应药物递送系统方面的研究进展。

引用

页码：65 / 75

页数：11

共 43 条

[1]

Chitosan-based nanoparticles: An overview of biomedical applications and its preparation.[J].Sweet Naskar;Suraj Sharma;Ketousetuo Kuotsu.Journal of Drug Delivery Science and Technology.2019,

[2]

Synthesis and characterization of cystamine conjugated chitosan-SS-mPEG based 5-Fluorouracil loaded polymeric nanoparticles for redox responsive drug release.[J].Gover Antoniraj M.;Angelin Tisha S.;Mahesh Ayyavu;Shanmugarathinam A.;Ruckmani Kandasamy.European Journal of Pharmaceutical Sciences.2018,

[3]

Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.[J].Ruirui Zhao;Tao Li;Guirong Zheng;Kai Jiang;Lulu Fan;Jingwei Shao.Biomaterials.2017,

[4]

Toxicity, pharmacokinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy [J].

Chen, Hongli ;

Nan, WenBin ;

Wei, Xiangjuan ;

Wang, Yan ;

Lv, Feng ;

Tang, Hongbo ;

Li, Yonghai ;

Zhou, Chenyan ;

Lin, Juntang ;

Zhu, Wuling ;

Zhang, Qiqing .

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2017, 45 (06) :1115-1122

[5]

Folate-conjugated thermosensitive O-maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib.[J].Marziyeh Fathi;Parham Sahandi Zangabad;Ayuob Aghanejad;Jaleh Barar;Hamid Erfan-Niya;Yadollah Omidi.Carbohydrate Polymers.2017,

[6]

Bioadhesive micelles of d-α-tocopherol polyethylene glycol succinate 1000: Synergism of chitosan and transferrin in targeted drug delivery.[J].Poornima Agrawal;Sonali;Rahul Pratap Singh;Gunjan Sharma;Abhishesh K. Mehata;Sanjay Singh;Chellapa V. Rajesh;Bajarangprasad L. Pandey;Biplob Koch;Madaswamy S. Muthu.Colloids and Surfaces B: Biointerfaces.2017,

[7]

Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.[J].Zhiyu He;Jose Luis Santos;Houkuan Tian;Huahua Huang;Yizong Hu;Lixin Liu;Kam W. Leong;Yongming Chen;Hai-Quan Mao.Biomaterials.2017,

[8]

Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.[J].Gao-Na Shi;Chuang-Nian Zhang;Rong Xu;Jin-Feng Niu;Hui-Juan Song;Xiu-Yuan Zhang;Wei-Wei Wang;Yan-Ming Wang;Chen Li;Xiao-Qing Wei;De-Ling Kong.Biomaterials.2017,

[9]

Synthesis and characterization of chitosan-coated magnetite nanoparticles and their application in curcumin drug delivery [J].